RCUS in the 13F filings
Arcus Biosciences Inc · CUSIP 03969F109
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 25
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 5 listed it in both
- Shares listed
- 20,951,456
- combined, among listed positions
- Reported value
- $645m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 13 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +938,680.
Managers listing RCUS in Q2 2026
25 of 25 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 4,049,757 shares now+2,884,505
- Citadel Advisors LLCexisting position · 3,135,057 shares now+1,805,122
- Two Sigma Investments LPexisting position · 635,404 shares now+322,714
- Millennium Management LLCnew position · 133,110 shares now+133,110
- Man Group PLCexisting position · 137,763 shares now+56,897
Reductions
- Marshall Wace LLPexisting position · 1,945,088 shares now-1,816,349
- Woodline Partners LPexisting position · 3,007,798 shares now-770,000
- Hudson Bay Capital Management LPexisting position · 140,000 shares now-216,535
- Wellington Management Group LLPexisting position · 5,895,448 shares now-194,068
- D. E. Shaw & Co.existing position · 96,417 shares now-162,983
New positions and exits
New (4)
Exited (4)
- Renaissance Technologies LLCwas $9.2m
- Tudor Investment Corpwas $4.7m
- Point72 Asset Management LPwas $2.8m
- Jane Street Group LLCwas $2.3m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 2 | $716k | n.a. | n.a. |
| Q2 2019 | 1 | $133k | n.a. | n.a. |
| Q3 2019 | 1 | $210k | n.a. | n.a. |
| Q1 2020 | 2 | $5.2m | n.a. | n.a. |
| Q2 2020 | 8 | $51m | n.a. | n.a. |
| Q3 2020 | 4 | $12m | n.a. | n.a. |
| Q4 2020 | 2 | $14m | n.a. | n.a. |
| Q1 2021 | 2 | $48m | n.a. | n.a. |
| Q2 2021 | 2 | $48m | n.a. | n.a. |
| Q3 2021 | 1 | $59m | n.a. | n.a. |
| Q4 2021 | 3 | $81m | n.a. | n.a. |
| Q1 2022 | 1 | $8.3m | n.a. | n.a. |
| Q2 2022 | 1 | $3.8m | n.a. | n.a. |
| Q3 2022 | 1 | $1.5m | n.a. | n.a. |
| Q4 2022 | 2 | $26m | n.a. | n.a. |
| Q1 2023 | 5 | $28m | n.a. | n.a. |
| Q2 2023 | 6 | $69m | n.a. | n.a. |
| Q3 2023 | 2 | $23m | n.a. | n.a. |
| Q4 2023 | 4 | $27m | 2 | 1 |
| Q1 2024 | 5 | $97m | 4 | 1 |
| Q2 2024 | 4 | $95m | 2 | 2 |
| Q3 2024 | 5 | $103m | 4 | 1 |
| Q4 2024 | 4 | $85m | 3 | 1 |
| Q1 2025 | 4 | $64m | 3 | 1 |
| Q2 2025 | 3 | $84m | 2 | 1 |
| Q3 2025 | 4 | $117m | 1 | 3 |
| Q4 2025 | 6 | $265m | 12 | 18 |
| Q1 2026 | 5 | $310m | 18 | 9 |
| Q2 2026 | 5 | $346m | 13 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RCUS and LLY →RCUS and JNJ →RCUS and VRTX →Choose a stock to compare with RCUS →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RCUS, latest filings →Back to the 13F Explorer →